Synaptics (SYNA) Financials

$58.60 -1.03 (-1.73%)

Closing price 05/30/2025 04:00 PM Eastern

Extended Trading

$58.80 +0.20 (+0.33%)

As of 05/30/2025 04:21 PM Eastern

Annual Income Statements for Synaptics

This table shows Synaptics' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	6/29/2024	6/24/2023	6/25/2022	6/26/2021	6/27/2020	6/29/2019	6/30/2018	6/24/2017	6/25/2016	6/27/2015	6/28/2014
Net Income / (Loss) Attributable to Common Shareholders	126	74	258	80	119	-23	-124	49	72	110	47
Consolidated Net Income / (Loss)	126	74	258	80	119	-23	-124	49	72	110	47
Net Income / (Loss) Continuing Operations	126	74	258	80	119	-23	-124	49	72	110	47
Total Pre-Tax Income	-125	126	321	120	159	-21	-82	61	76	160	75
Total Operating Income	-102	154	350	147	69	-6.30	-62	65	75	162	73
Total Gross Profit	440	716	943	611	543	497	480	524	582	579	436
Total Revenue	959	1,355	1,740	1,340	1,334	1,472	1,630	1,718	1,667	1,703	948
Operating Revenue	959	1,355	1,740	1,340	1,334	1,472	1,630	1,718	1,667	1,703	948
Total Cost of Revenue	520	639	797	728	791	975	1,150	1,195	1,085	1,124	511
Operating Cost of Revenue	520	639	797	728	791	975	1,150	1,195	1,085	1,124	511
Total Operating Expenses	541	562	593	464	474	503	542	459	506	417	364
Selling, General & Admin Expense	161	175	168	145	127	131	154	138	162	128	100
Research & Development Expense	336	351	367	313	303	343	363	292	311	293	193
Amortization Expense	17	35	39	33	12	12	13	12	19	14	1.00
Impairment Charge	16	0.00	-	-	-	-	-	-	6.70	0.00	0.00
Restructuring Charge	11	0.00	18	7.40	33	18	12	7.30	8.60	0.00	0.00
Total Other Income / (Expense), net	-23	-28	-30	-27	91	-15	-20	-3.40	0.40	-2.00	2.00
Interest Expense	65	56	38	30	23	21	22	6.00	4.80	3.80	0.00
Interest & Investment Income	42	27	3.00	2.90	7.90	6.70	2.30	1.90	2.10	1.80	2.00
Income Tax Expense	-250	52	65	31	39	0.30	41	12	3.40	50	28
Other Gains / (Losses), net	0.00	0.00	1.60	-9.10	-2.00	-1.80	-1.80	-0.30	0.00	0.00	-
Basic Earnings per Share	$3.20	$1.86	$6.60	$2.29	$3.54	($0.66)	($3.63)	$1.40	$1.97	$2.99	$1.34
Weighted Average Basic Shares Outstanding	39.20M	39.60M	39M	34.80M	33.60M	34.60M	34.20M	34.80M	36.60M	36.90M	34.80M
Diluted Earnings per Share	$3.16	$1.83	$6.33	$2.08	$3.41	($0.66)	($3.63)	$1.37	$1.91	$2.84	$1.26
Weighted Average Diluted Shares Outstanding	39.70M	40.20M	40.70M	38.30M	34.80M	34.60M	34.20M	35.60M	37.90M	38.90M	37.10M
Weighted Average Basic & Diluted Shares Outstanding	39.58M	38.58M	39.63M	38.85M	34.23M	32.91M	34.20M	34.90M	36.60M	36.90M	34.90M

This table shows Synaptics' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/29/2025	12/28/2024	9/28/2024	6/29/2024	3/30/2024	12/30/2023	9/30/2023	6/24/2023	3/25/2023	12/24/2022	9/24/2022
Net Income / (Loss) Attributable to Common Shareholders	-22	1.80	-23	208	-18	-9.00	-56	-23	10	22	65
Consolidated Net Income / (Loss)	-22	1.80	-23	208	-18	-9.00	-56	-23	10	22	65
Net Income / (Loss) Continuing Operations	-22	1.80	-23	208	-18	-9.00	-56	-23	10	22	65
Total Pre-Tax Income	-27	-26	-34	-37	-23	-24	-41	-44	27	39	104
Total Operating Income	-26	-15	-28	-31	-17	-18	-35	-38	34	46	112
Total Gross Profit	116	122	121	113	110	109	107	101	172	187	256
Total Revenue	267	267	258	247	237	237	238	227	327	353	448
Operating Revenue	267	267	258	247	237	237	238	227	327	353	448
Total Cost of Revenue	151	145	137	134	127	128	131	126	154	166	192
Operating Cost of Revenue	151	145	137	134	127	128	131	126	154	166	192
Total Operating Expenses	142	137	149	145	128	127	142	139	138	141	144
Selling, General & Admin Expense	35	50	50	39	41	40	42	46	42	42	45
Research & Development Expense	89	83	81	84	83	82	87	85	88	89	90
Amortization Expense	4.50	3.80	3.80	3.90	4.00	3.90	5.50	8.50	8.50	8.90	9.50
Impairment Charge	14	-	-	-	-	-	-	-	-	-	-
Restructuring Charge	0.50	0.80	14	1.40	-0.20	1.30	8.00	-	0.00	0.00	0.00
Total Other Income / (Expense), net	-1.10	-11	-5.90	-5.60	-5.90	-6.10	-5.40	-6.30	-7.00	-6.70	-8.30
Interest Expense	1.10	11	5.90	-	-	6.10	5.40	-	-	-	-
Income Tax Expense	-5.60	-28	-11	-245	-5.20	-15	15	-21	17	17	39
Basic Earnings per Share	($0.56)	$0.05	($0.58)	$5.32	($0.46)	($0.23)	($1.43)	($0.57)	$0.26	$0.55	$1.62
Weighted Average Basic Shares Outstanding	39M	39.70M	39.80M	39.20M	39.30M	39.20M	38.80M	39.60M	39.40M	39.80M	39.80M
Diluted Earnings per Share	($0.56)	$0.05	($0.58)	$5.28	($0.46)	($0.23)	($1.43)	($0.57)	$0.26	$0.55	$1.59
Weighted Average Diluted Shares Outstanding	39M	39.80M	39.80M	39.70M	39.30M	39.20M	38.80M	40.20M	39.90M	40.20M	40.70M
Weighted Average Basic & Diluted Shares Outstanding	38.55M	39.19M	40.06M	39.58M	39.50M	39.30M	39.20M	38.58M	39.52M	39.40M	39.87M

This table details how cash moves in and out of Synaptics' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	6/29/2024	6/24/2023	6/25/2022	6/26/2021	6/27/2020	6/29/2019	6/30/2018	6/24/2017	6/25/2016	6/27/2015	6/28/2014
Net Change in Cash & Equivalents	-48	101	-12	73	436	27	-67	16	-48	-47	92
Net Cash From Operating Activities	136	332	463	319	222	154	145	153	257	204	132
Net Cash From Continuing Operating Activities	136	332	463	319	222	154	145	153	257	204	132
Net Income / (Loss) Continuing Operations	126	74	258	80	119	-23	-124	49	72	110	47
Consolidated Net Income / (Loss)	126	74	258	80	119	-23	-124	49	72	110	47
Depreciation Expense	28	27	24	22	27	36	39	33	31	25	14
Amortization Expense	82	130	124	148	70	93	102	61	74	88	7.40
Non-Cash Adjustments To Reconcile Net Income	160	149	106	48	-49	56	73	60	71	35	32
Changes in Operating Assets and Liabilities, net	-259	-49	-49	22	55	-7.20	55	-49	8.40	-55	32
Net Cash From Investing Activities	-158	-6.00	-483	-523	120	-21	-439	-42	-27	-341	-58
Net Cash From Continuing Investing Activities	-158	-6.00	-483	-523	120	-21	-439	-42	-27	-341	-58
Purchase of Property, Plant & Equipment	-34	-34	-31	-21	-16	-24	-34	-31	-29	-52	-39
Acquisitions	-14	-16	-501	-627	-2.50	0.00	-404	-18	-4.60	-294	-20
Purchase of Investments	-137	0.00	-36	-5.00	0.00	0.00	-	-17	0.00	0.00	-
Sale of Property, Plant & Equipment	0.00	0.10	56	0.00	139	0.00	0.00	-	-	-	-
Divestitures	0.00	0.00	5.00	0.00	0.00	-	-	-	-	-	-
Sale and/or Maturity of Investments	27	44	24	96	0.00	2.80	0.00	7.50	6.60	4.90	0.00
Net Cash From Financing Activities	-25	-221	14	274	94	-107	227	-94	-281	94	19
Net Cash From Continuing Financing Activities	-25	-221	14	274	94	-107	227	-94	-281	94	19
Repayment of Debt	-4.10	-0.90	-11	-106	-0.70	0.00	-221	-20	-7.90	-4.20	-2.30
Repurchase of Common Equity	0.00	-184	0.00	0.00	-30	-119	-94	-88	-241	-121	-70
Issuance of Debt	0.00	0.00	600	400	100	0.00	515	0.00	0.00	245	0.00
Issuance of Common Equity	16	18	15	28	35	21	32	25	32	49	81
Other Financing Activities, net	-37	-55	-590	-48	-9.70	-9.40	-5.40	-5.50	-4.10	-3.20	10
Effect of Exchange Rate Changes	-0.90	-3.50	-6.60	2.20	0.00	0.10	0.00	-0.90	3.40	-3.70	0.00
Cash Interest Paid	63	52	25	9.60	3.70	3.60	3.80	6.00	5.00	3.10	0.00

This table details how cash moves in and out of Synaptics' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/29/2025	12/28/2024	9/28/2024	6/29/2024	3/30/2024	12/30/2023	9/30/2023	6/24/2023	3/25/2023	12/24/2022	9/24/2022
Net Change in Cash & Equivalents	-236	-258	-23	49	-18	45	-123	27	79	-49	44
Net Cash From Operating Activities	73	23	-11	65	-14	39	45	95	109	50	79
Net Cash From Continuing Operating Activities	73	23	-11	65	-14	39	45	95	109	50	79
Net Income / (Loss) Continuing Operations	-22	1.80	-23	208	-18	-9.00	-56	-23	10	22	65
Consolidated Net Income / (Loss)	-22	1.80	-23	208	-18	-9.00	-56	-23	10	22	65
Depreciation Expense	7.20	7.40	7.20	6.80	6.80	6.80	7.20	7.20	7.60	6.40	6.20
Amortization Expense	31	25	25	22	18	18	23	33	32	32	33
Non-Cash Adjustments To Reconcile Net Income	38	44	31	46	34	34	46	38	38	39	36
Changes in Operating Assets and Liabilities, net	19	-55	-51	-218	-55	-11	25	40	21	-49	-61
Net Cash From Investing Activities	-274	-5.50	-9.10	-11	-6.90	10	-150	22	-9.30	-21	2.30
Net Cash From Continuing Investing Activities	-274	-5.50	-9.10	-11	-6.90	10	-150	22	-9.30	-21	2.30
Purchase of Property, Plant & Equipment	-5.40	-4.70	-9.10	-7.70	-9.00	-10	-6.70	-5.20	-14	-9.10	-6.20
Acquisitions	-208	-0.80	0.00	-	-	-	-14	0.90	-	-16	0.00
Purchase of Investments	-61	-	0.00	-3.80	-	-	-133	-	-	-	0.00
Net Cash From Financing Activities	-35	-275	-3.50	-4.70	3.50	-5.80	-18	-87	-19	-80	-35
Net Cash From Continuing Financing Activities	-35	-275	-3.50	-4.70	3.50	-5.80	-18	-87	-19	-80	-35
Repayment of Debt	-0.30	-587	0.10	-1.50	0.20	-1.50	-1.30	-1.40	0.70	-1.50	1.30
Repurchase of Common Equity	-38	-	-	-	-	-	-	-83	-26	-61	-13
Issuance of Common Equity	6.20	-	7.70	-	7.40	-	8.50	-	8.80	0.30	8.50
Other Financing Activities, net	-2.90	-53	-11	-3.20	-4.10	-4.30	-25	-2.30	-3.10	-18	-31
Effect of Exchange Rate Changes	0.10	-0.10	0.70	-0.50	-0.90	1.10	-0.60	-2.80	-0.80	2.10	-2.00

This table presents Synaptics' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	6/29/2024	6/24/2023	6/25/2022	6/26/2021	6/27/2020	6/29/2019	6/30/2018	6/24/2017	6/25/2016	6/27/2015	6/28/2014
Total Assets	2,825	2,611	2,858	2,227	1,694	1,410	1,500	1,267	1,300	1,519	1,020
Total Current Assets	1,162	1,272	1,403	1,180	1,078	731	740	792	780	916	743
Cash & Equivalents	877	925	824	836	763	328	301	368	352	400	447
Accounts Receivable	142	164	322	228	195	230	289	255	253	325	195
Inventories, net	114	137	170	82	102	159	131	131	146	140	82
Prepaid Expenses	29	37	36	33	17	15	18	38	29	51	18
Plant, Property, & Equipment, net	76	66	63	91	84	103	118	114	113	123	81
Total Noncurrent Assets	1,587	1,273	1,392	956	532	576	643	361	407	480	197
Goodwill	816	816	807	570	361	373	373	207	207	207	61
Intangible Assets	288	299	390	302	93	145	219	101	160	235	82
Noncurrent Deferred & Refundable Income Taxes	346	68	-	-	-	-	-	-	-	-	-
Other Noncurrent Operating Assets	137	90	195	84	78	58	51	53	40	38	54
Total Liabilities & Shareholders' Equity	2,825	0.00	2,858	2,227	1,694	1,410	1,500	1,267	1,300	1,519	1,020
Total Liabilities	1,358	1,368	1,592	1,260	875	753	771	527	595	726	319
Total Current Liabilities	277	260	463	787	244	254	284	310	351	447	254
Short-Term Debt	6.00	6.00	6.00	0.00	0.00	-	-	15	19	11	0.00
Accounts Payable	88	46	142	98	61	98	157	136	173	189	97
Accrued Expenses	156	99	145	96	91	106	80	102	82	74	57
Current Employee Benefit Liabilities	27	46	91	76	60	30	25	32	40	36	31
Total Noncurrent Liabilities	1,081	1,108	1,128	473	631	499	487	216	244	280	65
Long-Term Debt	967	972	976	394	587	468	451	202	217	231	0.00
Other Noncurrent Operating Liabilities	114	136	153	79	44	30	36	14	19	15	65
Total Equity & Noncontrolling Interests	1,467	1,243	1,266	967	819	657	729	740	705	793	701
Total Preferred & Common Equity	1,467	1,243	1,266	967	819	657	729	740	705	793	701
Preferred Stock	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,467	1,243	1,266	967	819	657	729	740	705	793	701
Common Stock	1,107	1,009	924	1,392	1,340	1,266	1,195	1,005	929	844	740
Retained Earnings	1,238	1,112	1,039	781	701	584	606	714	665	593	483
Treasury Stock	-878	-878	-695	-1,205	-1,223	-1,192	-1,074	-980	-892	-652	-530

This table presents Synaptics' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/29/2025	12/28/2024	9/28/2024	3/30/2024	12/30/2023	9/30/2023	3/25/2023	12/24/2022	9/24/2022	3/26/2022
Total Assets	2,554	2,528	2,791	2,540	2,573	2,549	2,715	2,725	2,825	2,698
Total Current Assets	713	891	1,140	1,123	1,147	1,109	1,334	1,324	1,412	1,247
Cash & Equivalents	360	596	854	828	846	801	898	819	868	690
Short-Term Investments	61	-	-	0.50	2.60	23	36	40	44	65
Accounts Receivable	132	147	136	145	127	111	218	255	284	298
Inventories, net	133	120	120	114	125	132	148	178	179	146
Prepaid Expenses	26	28	31	35	47	41	34	33	37	48
Plant, Property, & Equipment, net	71	75	80	74	71	67	69	66	63	63
Total Noncurrent Assets	1,771	1,562	1,572	1,343	1,355	1,373	1,311	1,335	1,350	1,388
Goodwill	872	820	816	816	816	816	816	816	807	815
Intangible Assets	296	242	264	252	270	289	331	334	357	410
Noncurrent Deferred & Refundable Income Taxes	389	369	358	-	-	-	-	-	-	-
Other Noncurrent Operating Assets	213	131	133	275	268	268	164	185	186	164
Total Liabilities & Shareholders' Equity	2,554	2,528	2,791	2,540	2,573	2,549	2,715	2,725	2,825	2,698
Total Liabilities	1,167	1,151	1,324	1,304	1,353	1,344	1,394	1,425	1,500	1,540
Total Current Liabilities	248	230	254	211	253	246	269	299	365	393
Short-Term Debt	0.00	0.00	6.00	6.00	6.00	6.00	6.00	6.00	6.00	0.00
Accounts Payable	90	84	83	71	83	64	61	83	125	136
Accrued Expenses	111	115	136	99	104	103	94	113	128	139
Current Employee Benefit Liabilities	47	31	28	26	22	24	44	37	52	80
Total Noncurrent Liabilities	920	922	1,070	1,093	1,100	1,099	1,125	1,126	1,134	1,147
Long-Term Debt	834	833	966	968	969	970	973	974	975	983
Other Noncurrent Operating Liabilities	86	89	104	126	131	129	152	152	160	165
Total Equity & Noncontrolling Interests	1,387	1,376	1,467	1,235	1,220	1,204	1,321	1,300	1,325	1,158
Total Preferred & Common Equity	1,387	1,376	1,467	1,235	1,220	1,204	1,321	1,300	1,325	1,158
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	-
Total Common Equity	1,387	1,376	1,467	1,235	1,220	1,204	1,321	1,300	1,325	1,158
Common Stock	1,183	1,112	1,131	1,084	1,051	1,026	981	946	932	898
Retained Earnings	1,195	1,216	1,215	1,029	1,048	1,057	1,136	1,125	1,103	956
Treasury Stock	-991	-953	-878	-878	-878	-878	-795	-769	-708	-695

This table displays calculated financial ratios and metrics derived from Synaptics' official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	6/29/2024	6/24/2023	6/25/2022	6/26/2021	6/27/2020	6/29/2019	6/30/2018	6/24/2017	6/25/2016	6/27/2015	6/28/2014
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-29.20%	-22.11%	29.87%	0.43%	-9.39%	-9.70%	-5.12%	3.08%	-2.12%	79.74%	42.78%
EBITDA Growth	-97.56%	-37.99%	59.12%	16.72%	122.50%	53.40%	-50.09%	-13.30%	-33.37%	192.67%	-15.61%
EBIT Growth	-165.85%	-56.63%	142.04%	-15.52%	2,861.90%	89.82%	-194.65%	-16.48%	-51.73%	123.72%	-28.00%
NOPAT Growth	-178.91%	-67.78%	157.70%	107.92%	1,284.02%	89.82%	-183.61%	-27.84%	-35.75%	145.96%	-53.59%
Net Income Growth	70.65%	-71.42%	223.49%	-33.00%	618.78%	81.55%	-354.30%	-32.41%	-34.60%	136.40%	-52.78%
EPS Growth	72.68%	-71.09%	204.33%	-39.00%	616.67%	81.82%	-364.96%	-28.27%	-32.75%	125.40%	-56.40%
Operating Cash Flow Growth	-59.00%	-28.36%	44.96%	43.91%	43.84%	6.34%	-5.17%	-40.41%	25.72%	55.09%	28.89%
Free Cash Flow Firm Growth	-298.03%	130.89%	-351.38%	8.59%	170.50%	123.06%	-756.36%	-57.42%	144.15%	-376.16%	-328.41%
Invested Capital Growth	21.42%	-6.19%	161.20%	-18.22%	-19.49%	-9.24%	49.13%	0.19%	-7.44%	150.24%	67.23%
Revenue Q/Q Growth	2.14%	-15.53%	9.34%	3.89%	-1.30%	-5.97%	-2.28%	6.35%	-8.51%	10.66%	9.81%
EBITDA Q/Q Growth	-38.71%	-30.69%	10.01%	-8.77%	104.99%	-22.32%	0.00%	32.25%	-26.78%	9.91%	-10.25%
EBIT Q/Q Growth	6.36%	-50.66%	26.17%	-28.22%	601.61%	-127.16%	-28.69%	174.79%	-45.70%	2.94%	-16.58%
NOPAT Q/Q Growth	6.36%	-54.79%	24.83%	25.03%	249.24%	-103.38%	-75.85%	110.84%	-35.83%	-1.91%	-19.34%
Net Income Q/Q Growth	218.38%	-59.09%	33.70%	-47.49%	782.76%	-205.05%	-18.42%	104.18%	-34.72%	-2.80%	-18.79%
EPS Q/Q Growth	217.47%	-58.78%	33.54%	-50.48%	810.42%	-203.13%	-16.72%	98.55%	-33.68%	-3.73%	-24.55%
Operating Cash Flow Q/Q Growth	-17.84%	-15.28%	11.95%	19.19%	4.77%	29.91%	-21.83%	-29.77%	46.63%	-4.18%	6.48%
Free Cash Flow Firm Q/Q Growth	-283.86%	-19.91%	-532.96%	180.66%	64.18%	-37.37%	-13.85%	-19.84%	27.14%	3.35%	-55.08%
Invested Capital Q/Q Growth	13.21%	-5.78%	-0.96%	-50.98%	-8.92%	-7.95%	2.33%	-0.30%	-6.60%	3.91%	16.22%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	45.84%	52.83%	54.21%	45.63%	40.72%	33.77%	29.45%	30.47%	34.89%	33.98%	46.03%
EBITDA Margin	0.79%	23.03%	28.93%	23.61%	20.32%	8.27%	4.87%	9.26%	11.01%	16.17%	9.93%
Operating Margin	-10.59%	11.39%	20.14%	10.97%	5.17%	-0.43%	-3.80%	3.77%	4.51%	9.52%	7.65%
EBIT Margin	-10.59%	11.39%	20.45%	10.97%	13.04%	-0.43%	-3.80%	3.81%	4.70%	9.52%	7.65%
Profit (Net Income) Margin	13.09%	5.43%	14.80%	5.94%	8.91%	-1.56%	-7.61%	2.84%	4.33%	6.48%	4.93%
Tax Burden Percent	-100.80%	58.41%	80.34%	66.28%	74.53%	110.10%	151.71%	79.61%	95.50%	68.91%	62.68%
Interest Burden Percent	122.64%	81.66%	90.08%	81.70%	91.61%	330.16%	132.15%	93.73%	96.55%	98.77%	102.76%
Effective Tax Rate	0.00%	41.59%	20.16%	26.14%	24.22%	0.00%	0.00%	19.90%	4.50%	31.09%	37.32%
Return on Invested Capital (ROIC)	-4.99%	6.78%	29.49%	18.60%	7.25%	-0.53%	-5.90%	8.80%	11.74%	25.13%	22.39%
ROIC Less NNEP Spread (ROIC-NNEP)	276.64%	-15.35%	42.74%	27.96%	-359.61%	-13.27%	14,679.55%	11.06%	11.46%	25.59%	22.09%
Return on Net Nonoperating Assets (RNNOA)	14.26%	-0.91%	-6.43%	-9.68%	8.84%	-2.78%	-10.99%	-2.05%	-2.10%	-10.35%	-14.76%
Return on Equity (ROE)	9.27%	5.87%	23.06%	8.91%	16.09%	-3.30%	-16.89%	6.75%	9.64%	14.78%	7.64%
Cash Return on Invested Capital (CROIC)	-24.34%	13.17%	-59.77%	38.64%	28.85%	9.16%	-45.35%	8.61%	19.47%	-60.66%	-27.92%
Operating Return on Assets (OROA)	-3.74%	5.64%	13.99%	7.50%	11.21%	-0.43%	-4.48%	5.10%	5.55%	12.77%	8.47%
Return on Assets (ROA)	4.62%	2.69%	10.13%	4.06%	7.66%	-1.57%	-8.97%	3.80%	5.12%	8.69%	5.46%
Return on Common Equity (ROCE)	9.27%	5.87%	23.06%	8.91%	16.09%	-3.30%	-16.89%	6.75%	9.64%	14.78%	7.64%
Return on Equity Simple (ROE_SIMPLE)	8.56%	5.92%	20.33%	8.23%	14.50%	-3.48%	-17.02%	6.59%	10.24%	13.92%	6.66%
Net Operating Profit after Tax (NOPAT)	-71	90	280	109	52	-4.41	-43	52	72	112	45
NOPAT Margin	-7.41%	6.65%	16.08%	8.10%	3.91%	-0.30%	-2.66%	3.02%	4.31%	6.56%	4.80%
Net Nonoperating Expense Percent (NNEP)	-281.63%	22.13%	-13.25%	-9.36%	366.86%	12.74%	-14,685.45%	-2.26%	0.28%	-0.46%	0.31%
Cost of Revenue to Revenue	54.16%	47.17%	45.79%	54.37%	59.28%	66.23%	70.55%	69.53%	65.11%	66.02%	53.97%
SG&A Expenses to Revenue	16.81%	12.91%	9.68%	10.82%	9.52%	8.92%	9.45%	8.01%	9.70%	7.51%	10.55%
R&D to Revenue	35.05%	25.92%	21.11%	23.40%	22.68%	23.28%	22.28%	17.01%	18.67%	17.22%	20.34%
Operating Expenses to Revenue	56.43%	41.44%	34.07%	34.65%	35.55%	34.19%	33.25%	26.71%	30.37%	24.46%	38.37%
Earnings before Interest and Taxes (EBIT)	-102	154	356	147	174	-6.30	-62	65	78	162	73
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	7.60	312	503	316	271	122	79	159	184	275	94
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.38	2.58	4.03	5.37	2.34	1.53	2.39	2.78	2.73	4.01	4.59
Price to Tangible Book Value (P/TBV)	9.62	24.96	73.07	54.29	5.25	7.20	12.70	4.76	5.69	9.06	5.77
Price to Revenue (P/Rev)	3.63	2.37	2.93	3.88	1.44	0.68	1.07	1.20	1.15	1.87	3.40
Price to Earnings (P/E)	27.74	43.58	19.81	65.27	16.12	0.00	0.00	42.17	26.65	28.80	68.94
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	3.61%	2.29%	5.05%	1.53%	6.20%	0.00%	0.00%	2.37%	3.75%	3.47%	1.45%
Enterprise Value to Invested Capital (EV/IC)	2.29	2.53	3.79	9.05	2.71	1.44	2.15	3.24	3.07	4.75	10.92
Enterprise Value to Revenue (EV/Rev)	3.73	2.40	2.99	3.55	1.30	0.78	1.16	1.11	1.08	1.77	2.93
Enterprise Value to EBITDA (EV/EBITDA)	471.01	10.42	10.34	15.03	6.41	9.41	23.84	11.99	9.85	10.97	29.46
Enterprise Value to EBIT (EV/EBIT)	0.00	21.07	14.63	32.33	9.99	0.00	0.00	29.16	23.08	18.63	38.24
Enterprise Value to NOPAT (EV/NOPAT)	0.00	36.07	18.61	43.78	33.29	0.00	0.00	36.80	25.16	27.03	61.00
Enterprise Value to Operating Cash Flow (EV/OCF)	26.34	9.81	11.25	14.89	7.84	7.43	13.06	12.47	7.04	14.81	21.07
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	18.57	0.00	21.07	8.37	14.92	0.00	37.60	15.17	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.66	0.79	0.78	0.41	0.72	0.71	0.62	0.29	0.33	0.31	0.00
Long-Term Debt to Equity	0.66	0.78	0.77	0.41	0.72	0.71	0.62	0.27	0.31	0.29	0.00
Financial Leverage	0.05	0.06	-0.15	-0.35	-0.02	0.21	0.00	-0.19	-0.18	-0.40	-0.67
Leverage Ratio	2.01	2.18	2.28	2.19	2.10	2.10	1.88	1.78	1.88	1.70	1.40
Compound Leverage Factor	2.46	1.78	2.05	1.79	1.93	6.93	2.49	1.66	1.82	1.68	1.44
Debt to Total Capital	39.88%	44.03%	43.67%	28.97%	41.73%	41.60%	38.19%	22.67%	25.04%	23.41%	0.00%
Short-Term Debt to Total Capital	0.25%	0.27%	0.27%	0.00%	0.00%	0.00%	0.00%	1.57%	2.00%	1.09%	0.00%
Long-Term Debt to Total Capital	39.63%	43.76%	43.40%	28.97%	41.73%	41.60%	38.19%	21.10%	23.04%	22.32%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	60.12%	55.97%	56.33%	71.03%	58.27%	58.40%	61.81%	77.33%	74.96%	76.59%	100.00%
Debt to EBITDA	128.01	3.13	1.95	1.25	2.16	3.84	5.68	1.36	1.28	0.88	0.00
Net Debt to EBITDA	12.63	0.14	0.21	-1.40	-0.65	1.15	1.89	-0.95	-0.64	-0.57	0.00
Long-Term Debt to EBITDA	127.22	3.11	1.94	1.25	2.16	3.84	5.68	1.27	1.18	0.84	0.00
Debt to NOPAT	-13.68	10.85	3.51	3.63	11.23	-106.19	-10.40	4.19	3.28	2.17	0.00
Net Debt to NOPAT	-1.35	0.48	0.38	-4.07	-3.39	-31.86	-3.45	-2.91	-1.62	-1.41	0.00
Long-Term Debt to NOPAT	-13.60	10.78	3.49	3.63	11.23	-106.19	-10.40	3.90	3.02	2.07	0.00
Altman Z-Score	2.75	3.18	3.85	4.00	3.61	2.82	3.24	5.12	4.53	5.02	8.45
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.19	4.89	3.03	1.50	4.41	2.88	2.61	2.55	2.22	2.05	2.92
Quick Ratio	3.68	4.22	2.59	1.35	3.93	2.20	2.08	2.01	1.72	1.62	2.52
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-347	175	-567	226	208	77	-333	51	119	-270	-57
Operating Cash Flow to CapEx	402.07%	972.14%	0.00%	1,512.80%	0.00%	650.63%	425.22%	486.94%	897.20%	393.26%	340.05%
Free Cash Flow to Firm to Interest Expense	-5.31	3.16	-14.80	7.57	9.23	3.62	-15.00	8.45	24.82	-71.01	0.00
Operating Cash Flow to Interest Expense	2.08	5.97	12.08	10.71	9.86	7.27	6.53	25.48	53.46	53.71	0.00
Operating Cash Flow Less CapEx to Interest Expense	1.56	5.36	12.73	10.00	15.30	6.16	5.00	20.25	47.50	40.05	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.35	0.50	0.68	0.68	0.86	1.01	1.18	1.34	1.18	1.34	1.11
Accounts Receivable Turnover	6.26	5.58	6.32	6.32	6.27	5.67	5.99	6.77	5.78	6.55	5.52
Inventory Turnover	4.14	4.17	6.33	7.92	6.07	6.73	8.76	8.60	7.57	10.11	7.73
Fixed Asset Turnover	13.52	20.96	22.58	15.27	14.24	13.34	14.08	15.17	14.12	16.68	13.65
Accounts Payable Turnover	7.80	6.81	6.66	9.21	9.95	7.64	7.86	7.74	6.01	7.87	5.66
Days Sales Outstanding (DSO)	58.27	65.45	57.74	57.71	58.19	64.35	60.93	53.94	63.19	55.69	66.17
Days Inventory Outstanding (DIO)	88.23	87.62	57.66	46.10	60.16	54.26	41.67	42.44	48.19	36.12	47.19
Days Payable Outstanding (DPO)	46.82	53.56	54.85	39.64	36.67	47.76	46.44	47.15	60.75	46.36	64.52
Cash Conversion Cycle (CCC)	99.68	99.51	60.56	64.17	81.68	70.84	56.15	49.23	50.63	45.45	48.84
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,563	1,287	1,372	525	642	798	879	589	588	636	254
Invested Capital Turnover	0.67	1.02	1.83	2.29	1.85	1.76	2.22	2.92	2.72	3.83	4.67
Increase / (Decrease) in Invested Capital	276	-85	847	-117	-156	-81	290	1.10	-47	382	102
Enterprise Value (EV)	3,580	3,251	5,206	4,753	1,738	1,146	1,893	1,907	1,807	3,022	2,772
Market Capitalization	3,484	3,208	5,101	5,195	1,915	1,005	1,744	2,058	1,924	3,179	3,220
Book Value per Share	$37.14	$31.46	$31.97	$27.48	$24.07	$19.05	$21.07	$21.58	$19.14	$21.53	$19.47
Tangible Book Value per Share	$9.17	$3.25	$1.76	$2.72	$10.72	$4.05	$3.97	$12.60	$9.17	$9.53	$15.49
Total Capital	2,440	2,221	2,248	1,362	1,406	1,126	1,180	957	941	1,036	701
Total Debt	973	978	982	394	587	468	451	217	236	242	0.00
Total Long-Term Debt	967	972	976	394	587	468	451	202	217	231	0.00
Net Debt	96	44	106	-442	-177	141	150	-151	-117	-158	-447
Capital Expenditures (CapEx)	34	34	-25	21	-122	24	34	31	29	52	39
Debt-free, Cash-free Net Working Capital (DFCFNWC)	14	84	70	-443	70	149	155	129	96	81	41
Debt-free Net Working Capital (DFNWC)	891	1,018	946	393	834	477	456	497	448	481	488
Net Working Capital (NWC)	885	1,012	940	393	834	477	456	482	429	469	488
Net Nonoperating Expense (NNE)	-197	17	22	29	-67	18	81	3.02	-0.38	1.38	-1.25
Net Nonoperating Obligations (NNO)	96	44	106	-442	-177	141	150	-151	-117	-158	-447
Total Depreciation and Amortization (D&A)	109	158	148	169	97	128	141	94	105	113	22
Debt-free, Cash-free Net Working Capital to Revenue	1.48%	6.17%	4.02%	-33.09%	5.26%	10.15%	9.49%	7.50%	5.75%	4.74%	4.32%
Debt-free Net Working Capital to Revenue	92.88%	75.12%	54.38%	29.34%	62.49%	32.41%	27.95%	28.90%	26.88%	28.22%	51.51%
Net Working Capital to Revenue	92.26%	74.67%	54.03%	29.34%	62.49%	32.41%	27.95%	28.03%	25.75%	27.56%	51.51%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.20	$1.86	$6.60	$2.29	$3.54	($0.66)	($3.63)	$1.40	$1.97	$2.99	$1.34
Adjusted Weighted Average Basic Shares Outstanding	39.20M	39.60M	39M	34.80M	33.60M	34.60M	34.20M	34.80M	36.60M	36.90M	34.76M
Adjusted Diluted Earnings per Share	$3.16	$1.83	$6.33	$2.08	$3.41	($0.66)	($3.63)	$1.37	$1.91	$2.84	$1.26
Adjusted Weighted Average Diluted Shares Outstanding	39.70M	40.20M	40.70M	38.30M	34.80M	34.60M	34.20M	35.60M	37.90M	38.90M	37.11M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	39.58M	38.58M	39.63M	38.85M	34.23M	32.91M	35.36M	33.70M	34.81M	36.43M	36.74M
Normalized Net Operating Profit after Tax (NOPAT)	-53	90	294	89	77	7.98	-35	66	86	99	89
Normalized NOPAT Margin	-5.48%	6.65%	16.92%	6.63%	5.79%	0.54%	-2.14%	3.82%	5.16%	5.80%	9.42%
Pre Tax Income Margin	-12.99%	9.30%	18.42%	8.97%	11.95%	-1.41%	-5.02%	3.57%	4.54%	9.41%	7.86%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-1.56	2.78	9.29	4.93	7.73	-0.30	-2.79	10.90	16.31	42.68	0.00
NOPAT to Interest Expense	-1.09	1.62	7.30	3.64	2.32	-0.21	-1.95	8.64	14.96	29.42	0.00
EBIT Less CapEx to Interest Expense	-2.07	2.17	9.94	4.22	13.17	-1.42	-4.32	5.67	10.35	29.03	0.00
NOPAT Less CapEx to Interest Expense	-1.61	1.01	7.95	2.94	7.76	-1.33	-3.49	3.40	9.00	15.76	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	10.86%	84.35%	65.40%	0.00%
Augmented Payout Ratio	0.00%	249.32%	0.00%	0.00%	25.42%	-517.47%	-75.42%	191.19%	417.59%	175.27%	150.32%

This table displays calculated financial ratios and metrics derived from Synaptics' official financial filings.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/29/2025	12/28/2024	9/28/2024	6/29/2024	3/30/2024	12/30/2023	9/30/2023	6/24/2023	3/25/2023	12/24/2022	9/24/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	12.35%	12.74%	8.41%	8.84%	-27.34%	-32.88%	-46.95%	-52.29%	-30.53%	-16.03%	20.23%
EBITDA Growth	54.55%	133.33%	172.34%	-218.18%	-97.31%	-90.77%	-103.29%	-98.65%	-64.85%	33.33%	55.66%
EBIT Growth	-51.15%	15.08%	19.32%	18.16%	-185.66%	-145.43%	-133.94%	-126.69%	-68.66%	-45.20%	89.58%
NOPAT Growth	-51.15%	15.08%	19.32%	18.16%	-193.14%	-148.68%	-135.32%	-129.79%	-79.35%	-65.88%	31.82%
Net Income Growth	-20.44%	120.00%	58.45%	990.17%	-274.04%	-140.91%	-186.07%	-128.23%	-83.98%	-68.35%	60.70%
EPS Growth	-21.74%	121.74%	59.44%	1,026.32%	-276.92%	-141.82%	-189.94%	-127.94%	-83.65%	-67.84%	60.61%
Operating Cash Flow Growth	635.77%	-41.84%	-125.11%	-31.22%	-112.63%	-21.60%	-42.17%	-38.76%	-15.04%	-59.15%	34.65%
Free Cash Flow Firm Growth	-1,546.76%	-542.45%	-1,890.69%	-609.37%	-182.10%	131.39%	105.06%	107.71%	112.93%	115.02%	-244.72%
Invested Capital Growth	30.37%	19.77%	16.98%	21.42%	1.05%	-5.28%	-2.77%	-6.19%	-1.39%	-0.09%	32.95%
Revenue Q/Q Growth	-0.22%	3.69%	4.16%	4.26%	0.13%	-0.29%	4.58%	-30.40%	-7.51%	-21.20%	-5.94%
EBITDA Q/Q Growth	-29.17%	394.12%	230.77%	-244.44%	63.64%	253.19%	-313.64%	-96.72%	-14.10%	-45.42%	-12.01%
EBIT Q/Q Growth	-73.03%	46.48%	8.68%	-33.48%	2.92%	49.15%	7.37%	-239.71%	-30.96%	-62.01%	-27.18%
NOPAT Q/Q Growth	-73.03%	46.48%	8.68%	-78.74%	2.79%	49.15%	7.37%	-303.42%	-49.20%	-63.11%	-21.87%
Net Income Q/Q Growth	-1,311.11%	107.79%	-111.09%	1,250.83%	-101.11%	83.81%	-137.61%	-325.00%	-52.73%	-65.94%	-22.07%
EPS Q/Q Growth	-1,220.00%	108.62%	-110.98%	1,247.83%	-100.00%	83.92%	-150.88%	-319.23%	-52.73%	-65.41%	-22.06%
Operating Cash Flow Q/Q Growth	221.93%	300.00%	-117.54%	574.45%	-134.95%	-13.66%	-51.96%	-12.90%	117.00%	-36.31%	-49.13%
Free Cash Flow Firm Q/Q Growth	-58.11%	-10.74%	15.96%	-1,019.15%	-142.48%	348.21%	-76.10%	80.38%	19.73%	109.81%	63.60%
Invested Capital Q/Q Growth	11.62%	1.70%	1.46%	13.21%	2.54%	-0.68%	5.31%	-5.78%	-3.89%	1.96%	1.60%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	43.44%	45.73%	46.92%	45.84%	46.48%	45.99%	45.06%	44.52%	52.76%	52.87%	57.06%
EBITDA Margin	4.46%	6.29%	1.32%	-1.05%	0.76%	3.04%	-1.98%	0.97%	20.51%	22.09%	31.89%
Operating Margin	-9.87%	-5.69%	-11.02%	-12.57%	-7.33%	-7.55%	-14.81%	-16.72%	10.47%	13.06%	24.99%
EBIT Margin	-9.87%	-5.69%	-11.02%	-12.57%	-9.82%	-7.55%	-14.81%	-16.72%	8.33%	11.16%	23.14%
Profit (Net Income) Margin	-8.18%	0.67%	-8.96%	84.20%	-7.63%	-3.80%	-23.39%	-10.29%	3.18%	6.23%	14.42%
Tax Burden Percent	79.56%	-6.92%	67.35%	-567.57%	77.68%	37.50%	136.95%	52.82%	38.24%	55.84%	62.30%
Interest Burden Percent	104.18%	171.05%	120.77%	118.01%	100.00%	134.08%	115.34%	116.58%	100.00%	100.00%	100.00%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	61.76%	44.16%	37.70%
Return on Invested Capital (ROIC)	-4.51%	-2.72%	-5.14%	-5.92%	-3.51%	-3.93%	-8.63%	-11.93%	4.67%	8.96%	23.14%
ROIC Less NNEP Spread (ROIC-NNEP)	-5.73%	4.15%	-7.53%	323.45%	-9.74%	-1.07%	-36.75%	-7.64%	2.71%	7.40%	14.24%
Return on Net Nonoperating Assets (RNNOA)	-1.22%	0.58%	-0.76%	16.67%	-0.72%	-0.11%	-3.20%	-0.46%	0.30%	1.50%	0.71%
Return on Equity (ROE)	-5.73%	-2.14%	-5.90%	10.75%	-4.23%	-4.03%	-11.83%	-12.38%	4.97%	10.46%	23.85%
Cash Return on Invested Capital (CROIC)	-30.81%	-22.35%	-20.16%	-24.34%	-6.58%	2.55%	3.17%	13.17%	15.89%	17.59%	-3.91%
Operating Return on Assets (OROA)	-4.02%	-2.25%	-4.04%	-4.44%	-3.51%	-2.93%	-6.31%	-8.28%	4.94%	7.37%	18.24%
Return on Assets (ROA)	-3.34%	0.27%	-3.29%	29.72%	-2.73%	-1.47%	-9.97%	-5.10%	1.89%	4.11%	11.36%
Return on Common Equity (ROCE)	-5.73%	-2.14%	-5.90%	10.75%	-4.23%	-4.03%	-11.83%	-12.38%	4.97%	10.46%	23.85%
Return on Equity Simple (ROE_SIMPLE)	11.91%	12.27%	10.77%	0.00%	-8.59%	-6.36%	-3.87%	0.00%	13.62%	18.03%	21.27%
Net Operating Profit after Tax (NOPAT)	-18	-11	-20	-22	-12	-13	-25	-27	13	26	70
NOPAT Margin	-6.91%	-3.98%	-7.71%	-8.80%	-5.13%	-5.29%	-10.37%	-11.70%	4.00%	7.29%	15.57%
Net Nonoperating Expense Percent (NNEP)	1.22%	-6.87%	2.39%	-329.38%	6.23%	-2.86%	28.12%	-4.28%	1.96%	1.56%	8.90%
Return On Investment Capital (ROIC_SIMPLE)	-0.83%	-0.48%	-	-	-	-0.57%	-	-	-	-	-
Cost of Revenue to Revenue	56.56%	54.27%	53.09%	54.16%	53.52%	54.01%	54.94%	55.48%	47.24%	47.13%	42.94%
SG&A Expenses to Revenue	13.02%	18.53%	19.40%	15.68%	17.07%	16.75%	17.80%	20.33%	12.77%	12.01%	9.98%
R&D to Revenue	33.23%	31.18%	31.55%	34.11%	35.15%	34.60%	36.39%	37.18%	26.91%	25.29%	19.97%
Operating Expenses to Revenue	53.30%	51.42%	57.94%	58.41%	53.81%	53.54%	59.87%	61.24%	42.28%	39.82%	32.07%
Earnings before Interest and Taxes (EBIT)	-26	-15	-28	-31	-23	-18	-35	-38	27	39	104
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	12	17	3.40	-2.60	1.80	7.20	-4.70	2.20	67	78	143
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.78	2.25	2.12	2.38	3.10	3.66	2.87	2.58	3.24	2.89	3.02
Price to Tangible Book Value (P/TBV)	11.31	9.85	8.02	9.62	22.99	33.50	34.79	24.96	24.70	24.98	24.76
Price to Revenue (P/Rev)	2.38	3.06	3.17	3.63	4.08	4.35	3.01	2.37	2.67	2.15	2.20
Price to Earnings (P/E)	14.96	18.32	19.65	27.74	0.00	0.00	0.00	43.58	25.06	16.66	14.66
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	6.69%	5.46%	5.09%	3.61%	0.00%	0.00%	0.00%	2.29%	3.99%	6.00%	6.82%
Enterprise Value to Invested Capital (EV/IC)	1.60	2.07	2.03	2.29	2.88	3.42	2.66	2.53	3.17	2.73	2.92
Enterprise Value to Revenue (EV/Rev)	2.78	3.30	3.29	3.73	4.24	4.47	3.15	2.40	2.70	2.22	2.24
Enterprise Value to EBITDA (EV/EBITDA)	97.76	131.63	205.40	471.01	320.93	58.42	23.06	10.42	9.61	6.75	7.34
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	507.35	21.07	13.83	10.41	10.05
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	724.78	36.07	21.70	15.57	13.66
Enterprise Value to Operating Cash Flow (EV/OCF)	19.25	53.11	40.77	26.34	24.06	15.99	12.07	9.81	11.05	9.44	8.42
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	130.36	82.68	18.57	19.78	15.49	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.60	0.61	0.66	0.66	0.79	0.80	0.81	0.79	0.74	0.75	0.74
Long-Term Debt to Equity	0.60	0.61	0.66	0.66	0.78	0.79	0.81	0.78	0.74	0.75	0.74
Financial Leverage	0.21	0.14	0.10	0.05	0.07	0.10	0.09	0.06	0.11	0.20	0.05
Leverage Ratio	1.94	1.96	2.00	2.01	2.06	2.10	2.12	2.18	2.18	2.24	1.98
Compound Leverage Factor	2.02	3.36	2.41	2.37	2.06	2.82	2.45	2.54	2.18	2.24	1.98
Debt to Total Capital	37.56%	37.69%	39.85%	39.88%	44.08%	44.41%	44.75%	44.03%	42.56%	42.97%	42.53%
Short-Term Debt to Total Capital	0.00%	0.00%	0.25%	0.25%	0.27%	0.27%	0.28%	0.27%	0.26%	0.26%	0.26%
Long-Term Debt to Total Capital	37.56%	37.69%	39.60%	39.63%	43.81%	44.13%	44.48%	43.76%	42.30%	42.71%	42.27%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	62.44%	62.31%	60.16%	60.12%	55.92%	55.59%	55.25%	55.97%	57.44%	57.03%	57.47%
Debt to EBITDA	28.28	32.91	61.90	128.01	78.52	12.39	6.25	3.13	2.17	1.71	1.77
Net Debt to EBITDA	13.99	9.34	7.54	12.63	11.70	1.60	0.97	0.14	0.10	0.21	0.12
Long-Term Debt to EBITDA	28.28	32.91	61.52	127.22	78.04	12.31	6.21	3.11	2.16	1.70	1.76
Debt to NOPAT	-11.80	-12.91	-14.65	-13.68	-12.82	-24.47	196.30	10.85	4.91	3.94	3.29
Net Debt to NOPAT	-5.84	-3.67	-1.78	-1.35	-1.91	-3.16	30.42	0.48	0.23	0.49	0.23
Long-Term Debt to NOPAT	-11.80	-12.91	-14.56	-13.60	-12.74	-24.32	195.09	10.78	4.88	3.91	3.27
Altman Z-Score	2.52	2.98	2.72	2.83	3.10	3.35	2.93	2.94	3.52	3.30	3.35
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.88	3.88	4.49	4.19	5.32	4.53	4.52	4.89	4.96	4.42	3.86
Quick Ratio	2.24	3.23	3.90	3.68	4.62	3.85	3.81	4.22	4.28	3.72	3.27
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-438	-277	-250	-297	-27	63	14	58	32	27	-276
Operating Cash Flow to CapEx	1,359.26%	485.11%	-125.27%	844.16%	-152.22%	376.92%	677.61%	1,549.18%	791.97%	561.80%	1,453.70%
Free Cash Flow to Firm to Interest Expense	-397.92	-25.63	-42.37	0.00	0.00	10.26	2.59	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	66.73	2.11	-1.93	0.00	0.00	6.43	8.41	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	61.82	1.68	-3.47	0.00	0.00	4.72	7.17	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.41	0.40	0.37	0.35	0.36	0.39	0.43	0.50	0.59	0.66	0.79
Accounts Receivable Turnover	7.51	7.39	7.93	6.26	5.18	5.39	5.79	5.58	6.21	6.16	6.56
Inventory Turnover	4.59	4.44	4.18	4.14	3.91	3.56	3.71	4.17	4.93	5.05	6.08
Fixed Asset Turnover	14.33	13.80	13.33	13.52	13.14	15.03	17.50	20.96	24.29	28.46	23.35
Accounts Payable Turnover	7.04	6.50	7.14	7.80	7.77	6.51	6.11	6.81	7.37	7.23	6.94
Days Sales Outstanding (DSO)	48.61	49.37	46.03	58.27	70.51	67.71	63.02	65.45	58.76	59.23	55.68
Days Inventory Outstanding (DIO)	79.56	82.24	87.22	88.23	93.41	102.46	98.33	87.62	74.09	72.22	60.08
Days Payable Outstanding (DPO)	51.83	56.15	51.09	46.82	46.97	56.10	59.71	53.56	49.55	50.47	52.59
Cash Conversion Cycle (CCC)	76.34	75.46	82.16	99.68	116.95	114.06	101.65	99.51	83.31	80.98	63.17
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,800	1,613	1,586	1,563	1,381	1,346	1,356	1,287	1,366	1,421	1,394
Invested Capital Turnover	0.65	0.68	0.67	0.67	0.68	0.74	0.83	1.02	1.17	1.23	1.49
Increase / (Decrease) in Invested Capital	419	266	230	276	14	-75	-39	-85	-19	-1.30	346
Enterprise Value (EV)	2,884	3,330	3,225	3,580	3,980	4,598	3,602	3,251	4,325	3,875	4,067
Market Capitalization	2,471	3,094	3,106	3,484	3,834	4,472	3,451	3,208	4,280	3,754	3,998
Book Value per Share	$35.39	$34.35	$37.07	$37.14	$31.43	$31.13	$31.21	$31.46	$33.53	$32.62	$33.29
Tangible Book Value per Share	$5.57	$7.84	$9.78	$9.17	$4.24	$3.41	$2.57	$3.25	$4.40	$3.77	$4.06
Total Capital	2,221	2,209	2,439	2,440	2,209	2,195	2,180	2,221	2,300	2,280	2,306
Total Debt	834	833	972	973	974	975	976	978	979	980	981
Total Long-Term Debt	834	833	966	967	968	969	970	972	973	974	975
Net Debt	413	236	118	96	145	126	151	44	45	121	69
Capital Expenditures (CapEx)	5.40	4.70	9.10	7.70	9.00	10	6.70	6.10	14	8.90	5.40
Debt-free, Cash-free Net Working Capital (DFCFNWC)	44	65	38	14	89	51	45	84	138	172	141
Debt-free Net Working Capital (DFNWC)	465	661	892	891	918	900	869	1,018	1,071	1,031	1,053
Net Working Capital (NWC)	465	661	886	885	912	894	863	1,012	1,065	1,025	1,047
Net Nonoperating Expense (NNE)	3.39	-12	3.22	-230	5.92	-3.53	31	-3.20	2.68	3.74	5.17
Net Nonoperating Obligations (NNO)	413	236	118	96	145	126	151	44	45	121	69
Total Depreciation and Amortization (D&A)	38	32	32	29	25	25	31	40	40	39	39
Debt-free, Cash-free Net Working Capital to Revenue	4.21%	6.40%	3.92%	1.48%	9.48%	5.00%	3.91%	6.17%	8.57%	9.83%	7.75%
Debt-free Net Working Capital to Revenue	44.77%	65.44%	91.08%	92.88%	97.69%	87.51%	75.92%	75.12%	66.79%	58.97%	57.99%
Net Working Capital to Revenue	44.77%	65.44%	90.46%	92.26%	97.05%	86.92%	75.40%	74.67%	66.41%	58.63%	57.66%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.56)	$0.05	($0.58)	$5.32	($0.46)	($0.23)	($1.43)	($0.57)	$0.26	$0.55	$1.62
Adjusted Weighted Average Basic Shares Outstanding	39M	39.70M	39.80M	39.20M	39.30M	39.20M	38.80M	39.60M	39.40M	39.80M	39.80M
Adjusted Diluted Earnings per Share	($0.56)	$0.05	($0.58)	$5.28	($0.46)	($0.23)	($1.43)	($0.57)	$0.26	$0.55	$1.59
Adjusted Weighted Average Diluted Shares Outstanding	39M	39.80M	39.80M	39.70M	39.30M	39.20M	38.80M	40.20M	39.90M	40.20M	40.70M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	38.55M	39.19M	40.06M	39.58M	39.50M	39.30M	39.20M	38.58M	39.52M	39.40M	39.87M
Normalized Net Operating Profit after Tax (NOPAT)	-8.40	-10	-9.94	-21	-12	-12	-19	-27	24	26	70
Normalized NOPAT Margin	-3.15%	-3.77%	-3.86%	-8.40%	-5.19%	-4.90%	-8.01%	-11.70%	7.33%	7.29%	15.57%
Pre Tax Income Margin	-10.28%	-9.73%	-13.31%	-14.83%	-9.82%	-10.13%	-17.08%	-19.49%	8.33%	11.16%	23.14%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-23.91	-1.41	-4.81	0.00	0.00	-2.93	-6.52	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	-16.74	-0.99	-3.37	0.00	0.00	-2.05	-4.56	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	-28.82	-1.84	-6.36	0.00	0.00	-4.64	-7.76	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	-21.65	-1.42	-4.91	0.00	0.00	-3.76	-5.80	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	67.98%	44.11%	0.00%	0.00%	-78.61%	-140.46%	0.00%	249.32%	55.64%	31.78%	4.75%

Frequently Asked Questions About Synaptics' Financials

When does Synaptics's fiscal year end?

According to the most recent income statement we have on file, Synaptics' financial year ends in June. Their financial year 2024 ended on June 29, 2024.

How has Synaptics' net income changed over the last 10 years?

Synaptics' net income appears to be on an upward trend, with a most recent value of $125.60 million in 2024, rising from $46.70 million in 2014. The previous period was $73.60 million in 2023. Find out what analysts predict for Synaptics in the coming months.

What is Synaptics's operating income?

Synaptics's total operating income in 2024 was -$101.60 million, based on the following breakdown:

Total Gross Profit: $439.80 million
Total Operating Expenses: $541.40 million

How has Synaptics revenue changed over the last 10 years?

Over the last 10 years, Synaptics' total revenue changed from $947.50 million in 2014 to $959.40 million in 2024, a change of 1.3%.

How much debt does Synaptics have?

Synaptics' total liabilities were at $1.36 billion at the end of 2024, a 0.7% decrease from 2023, and a 325.6% increase since 2014.

How much cash does Synaptics have?

In the past 10 years, Synaptics' cash and equivalents has ranged from $301 million in 2018 to $924.70 million in 2023, and is currently $876.90 million as of their latest financial filing in 2024.

How has Synaptics' book value per share changed over the last 10 years?

Over the last 10 years, Synaptics' book value per share changed from 19.47 in 2014 to 37.14 in 2024, a change of 90.8%.

Related Companies

This page (NASDAQ:SYNA) was last updated on 5/31/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Synaptics (SYNA) Financials

Frequently Asked Questions About Synaptics' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Synaptics (SYNA) Financials

Annual Income Statements for Synaptics

Quarterly Income Statements for Synaptics

Annual Cash Flow Statements for Synaptics

Quarterly Cash Flow Statements for Synaptics

Annual Balance Sheets for Synaptics

Quarterly Balance Sheets for Synaptics

Annual Metrics And Ratios for Synaptics

Quarterly Metrics And Ratios for Synaptics

Frequently Asked Questions About Synaptics' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools